Cysteinyl leukotrienes are involved in angiotensin II-induced contraction of aorta from spontaneously hypertensive rats

Cardiovascular Research

Volumn 49, Issue 1, 2001, Pages 152-160

  Spector, Stephen A ^a   Hsia, Karen ^a   Yong, Florence H ^b,g   Cabral, Sheila ^a   Fenton, Terrence ^b   Fletcher, Courtney V ^c   McNamara, James ^d   Mofenson, Lynne M ^e   Starr, Stuart E ^f  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e Eunice Kennedy Shriver National Institute of Child Health and Human Health   (United States)

^f CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^g GENZYME CORPORATION   (United States)

Author keywords

Angiotensin; Arteries; Contractile function; Hypertension; Lipid metabolism; Receptors

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ARACHIDONATE 5 LIPOXYGENASE; DOCEBENONE; PEPTIDOLEUKOTRIENE; VERLUKAST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; CONTROLLED STUDY; HYPERTENSION; LIPID METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTILITY; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR ENDOTHELIUM;

ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; CULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERTENSION; LEUKOTRIENES; MALE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SRS-A; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0034751013     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(00)00238-8     Document Type: Article

References (53)

1. The role of eicosanoids in angiotensin II-dependent hypertension
2. Selective inhibition of angiotensin II-mediated vasoconstriction by lipoxygenase blockade
3. Inhibition of lipoxygenase pathway reduces blood pressure in renovascular hypertensive rats
4. The lipoxygenase inhibitor phenidone is a potent hypotensive agent in the spontaneously hypertensive rat
5. Effects of the leukotrienes on the vasculature and blood pressure of different species
6. A second cysteinyl leukotriene receptor in human lung
7. 4 on human isolated saphenous veins
8. Preferential vasoconstriction to cysteinyl leukotrienes in the human saphenous vein compared with the internal mammary artery. Implication for graft performance
9. Differential leukotriene constrictor responses in human atherosclerotic coronary arteries
10. 4: Importance of the magnitude of preload
11. 4 potentiates the contractile effects of epinephrine and norepinephrine on rat aortic rings
12. 4 is a potent constrictor of rat mesenteric vessels
13. 4 in spontaneously hypertensive rats
14. Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats
15. 4 hydrolase expression in the heart of angiotensin II-induced hypertensive rat
16. Formation of monohydroxyeicosatetraenoic acids from arachidonic acid by cultured rabbit aortic smooth muscle cells
17. Leukotriene biosynthesis by canine and human coronary arteries
18. Endothelial dysfunction and subendothelial monocyte macrophages in hypertension. Effect of angiotensin converting enzyme inhibition
19. 2,3,5-Trimethyl-6-(12 hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone (AA861), a selective inhibitor of the 5-lipoxygenase reaction and the biosynthesis of slow-reacting substance of anaphylaxis
20. 1 receptor
21. 2) receptor
22. Role of endothelium in endothelin-evoked contractions in the rat aorta
23. The current endothelin receptor classification: Time for reconsideration?
24. Angiotensin II receptor pharmacology
25. Alteration of cyclo-oxygenase products and NO in response to angiotensin II of resistance arteries from the spontaneously hypertensive rats
26. Altered angiotensin II-induced small artery contraction during the development of hypertension in spontaneously hypertensive rats
27. Pre- and postsynaptic effects of angiotensins in the femoral artery of spontaneously hypertensive and Wistar-Kyoto rats
28. Angiotensin II-induced renal vasoconstriction in genetic hypertension
29. Augmented endothelium-dependent contraction to angiotensin II in the SHR aorta: Role of an inducible cyclooxygenase metabolite
30. Endothelium-dependent modulation of angiotensin II-induced contraction in blood vessels
31. Endothelial AT1-mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery
32. Quantitative changes of maximum contractile response to norepinephrine in mesenteric arteries from spontaneously hypertensive rats during the development of hypertension
33. Platelet lipoxygenases in spontaneously hypertensive rats
34. Selective inhibition of angiotensin II-mediated aldosterone secretion by 5-hydroxyeicosatetraenoic acid
35. Generation of a leukotriene-like substance from porcine vascular and other tissues
36. Release of eicosanoids from cultured rat aortic endothelial cells; studies with arachidonic acid and calcium ionophore A23187
37. Synthesis of leukotrienes by freshly harvested endothelial cells
38. Arachidonate cascade in mesenteric blood vessels and platelets of spontaneously hypertensive rats
39. Production of eicosanoids and angiotensin II in resistance vessels in spontaneously hypertensive rats
40. Altered gene expression of prostacyclin synthase and prostacyclin receptor in the thoracic aorta of spontaneously hypertensive rats
41. 2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR
42. Signal transduction mechanisms involved in angiotensin-(1-7)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells
43. Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: Subtypes of angiotensin receptors involved
44. Cytosolic calcium changes induced by angiotensin II in human peripheral blood mononuclear cells are mediated via angiotensin II subtype 1 receptors
45. Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages
46. 2-receptor mediates inhibition of cell proliferation in coronary endothelial cells
47. Role of the lipoxygenase pathway in angiotensin II-induced vascular smooth muscle cell hypertrophy
48. Angiotensin II increases macrophage-mediated modification of low density lipoprotein via lipoxygenase-dependent pathway
49. 4 causes pulmonary vasoconstriction, not inhibited by meclofenamate
50. Leukotriene receptor on human pulmonary vascular endothelium
51. A second cysteinyl leukotriene receptor in human lung
52. Regulation of 12-lipoxygenase by cytokines in vascular smooth muscle cells
53. Lipoxygenase products increase monocyte adhesion to human aortic endothelial cells